• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤首次发现的季节作为预测乳腺癌生存的一个独立变量。

Season of initial discovery of tumour as an independent variable predicting survival in breast cancer.

作者信息

Mason B H, Holdaway I M, Stewart A W, Neave L M, Kay R G

机构信息

Department of Surgery, Auckland Hospital, New Zealand.

出版信息

Br J Cancer. 1990 Jan;61(1):137-41. doi: 10.1038/bjc.1990.28.

DOI:10.1038/bjc.1990.28
PMID:2297485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1971327/
Abstract

The month of initial detection of tumour was recorded in 2,245 patients with breast cancer and correlated with survival over a follow-up period of 1.5-10 years. Women who initially detected their breast cancer in spring/summer had a significantly longer survival than those detecting their tumour at other times of the year. Overall, this relationship was independent of nodal status, tumour size and hormone receptor status. However, when patients were divided into groups the survival advantage was significantly associated with receptor status and age. Women aged greater than or equal to 50 years with ER-positive and PR-positive tumours who discovered their initial tumour in spring/summer had significantly better survival than those detecting their tumours at other times of the year. Survival was also longer in women aged less than 50 years with receptor-negative tumours who initially found their tumours in spring/summer compared with the rest of the year. This study suggests that the season of first detection of a breast cancer relates significantly to the later behaviour of the tumour, and may reflect seasonal changes in hormone dependent growth.

摘要

在2245例乳腺癌患者中记录了肿瘤首次被检测出的月份,并将其与1.5至10年随访期内的生存率进行关联分析。在春季/夏季首次检测出乳腺癌的女性,其生存期显著长于在一年中其他时间检测出肿瘤的女性。总体而言,这种关系独立于淋巴结状态、肿瘤大小和激素受体状态。然而,当将患者分组时,生存优势与受体状态和年龄显著相关。年龄大于或等于50岁、肿瘤雌激素受体(ER)阳性且孕激素受体(PR)阳性、在春季/夏季首次检测出肿瘤的女性,其生存期显著优于在一年中其他时间检测出肿瘤的女性。与一年中的其他时间相比,年龄小于50岁、受体阴性、在春季/夏季首次检测出肿瘤的女性生存期也更长。这项研究表明,乳腺癌首次被检测出的季节与肿瘤后期行为显著相关,可能反映了激素依赖性生长的季节性变化。

相似文献

1
Season of initial discovery of tumour as an independent variable predicting survival in breast cancer.肿瘤首次发现的季节作为预测乳腺癌生存的一个独立变量。
Br J Cancer. 1990 Jan;61(1):137-41. doi: 10.1038/bjc.1990.28.
2
Season of tumour detection influences factors predicting survival of patients with breast cancer.肿瘤检测季节会影响预测乳腺癌患者生存情况的因素。
Breast Cancer Res Treat. 1990 Jan;15(1):27-37. doi: 10.1007/BF01811887.
3
Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status.乳腺癌检测中的季节性变化:与肿瘤孕激素受体状态的相关性。
Breast Cancer Res Treat. 1985;5(2):171-6. doi: 10.1007/BF01805991.
4
Association between season of first detection of breast cancer and disease progression.首次发现乳腺癌的季节与疾病进展之间的关联。
Breast Cancer Res Treat. 1987;9(3):227-32. doi: 10.1007/BF01806384.
5
Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.乳腺癌中的雌激素和孕激素受体:与肿瘤组织病理学及患者生存率的关系
Anticancer Res. 1984 Nov-Dec;4(6):383-9.
6
Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.激素受体状态和有丝分裂活性作为女性乳腺癌复发和死亡的风险因素。
Anticancer Res. 1991 Sep-Oct;11(5):1701-6.
7
Oestrogen receptors revisited: long-term follow up of over five thousand breast cancer patients.雌激素受体再探讨:对五千多名乳腺癌患者的长期随访
ANZ J Surg. 2004 Nov;74(11):957-60. doi: 10.1111/j.1445-1433.2004.03215.x.
8
Progesterone and estrogen receptors as prognostic variables in breast cancer.孕激素和雌激素受体作为乳腺癌的预后变量
Cancer Res. 1983 Jun;43(6):2985-90.
9
Seasonal change in the concentration of progesterone receptor in breast cancer.乳腺癌中孕激素受体浓度的季节性变化。
Cancer Res. 1990 Sep 15;50(18):5883-6.
10
Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.人乳腺癌中雌激素、孕激素、雄激素和糖皮质激素受体的分布、频率及定量分析。
Cancer Res. 1979 May;39(5):1447-54.

引用本文的文献

1
No Impact of Seasonality of Diagnoses on Baseline Tumor Immune Infiltration, Response to Treatment, and Prognosis in BC Patients Treated with NAC.诊断的季节性对接受新辅助化疗(NAC)治疗的乳腺癌(BC)患者的基线肿瘤免疫浸润、治疗反应和预后无影响。
Cancers (Basel). 2022 Jun 23;14(13):3080. doi: 10.3390/cancers14133080.
2
Seasonality pattern of breast, colorectal, and prostate cancer is dependent on latitude.乳腺癌、结直肠癌和前列腺癌的季节性模式取决于纬度。
Med Sci Monit. 2014 May 19;20:818-24. doi: 10.12659/MSM.890062.
3
Seasonal variations of cancer incidence and prognosis.癌症发病率和预后的季节性变化。
Dermatoendocrinol. 2010 Apr;2(2):55-7. doi: 10.4161/derm.2.2.12664.
4
Seasonal variation in the diagnosis of cancer: a study based on national cancer registration in Sweden.癌症诊断中的季节性变化:一项基于瑞典国家癌症登记的研究。
Br J Cancer. 2003 May 6;88(9):1358-60. doi: 10.1038/sj.bjc.6600901.
5
Seasonal variations in the presentation and growth of thyroid cancer.甲状腺癌的临床表现及生长的季节性变化。
Br J Cancer. 1998 Apr;77(7):1174-9. doi: 10.1038/bjc.1998.195.
6
Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: relation to age and lymph node status.雌激素和孕激素受体在乳腺癌患者中的预后作用:与年龄和淋巴结状态的关系。
J Clin Pathol. 1996 Nov;49(11):920-5. doi: 10.1136/jcp.49.11.920.
7
Does the month of diagnosis affect survival of cancer patients?确诊月份会影响癌症患者的生存率吗?
Br J Cancer. 1993 Apr;67(4):838-41. doi: 10.1038/bjc.1993.153.
8
Association between the month of diagnosis and prognosis in breast carcinoma.乳腺癌诊断月份与预后之间的关联。
Br J Cancer. 1991 Oct;64(4):753-6. doi: 10.1038/bjc.1991.393.
9
Seasonal changes in serum melatonin in women with previous breast cancer.既往患乳腺癌女性血清褪黑素的季节性变化
Br J Cancer. 1991 Jul;64(1):149-53. doi: 10.1038/bjc.1991.259.
10
Breast carcinoma: periodicity in presentation of metastatic tumour growth in the axilla.乳腺癌:腋窝转移性肿瘤生长表现的周期性
Clin Exp Metastasis. 1992 Sep;10(5):329-36. doi: 10.1007/BF00058172.

本文引用的文献

1
Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer.雌激素受体阳性乳腺癌患者夜间血浆褪黑素峰值降低。
Science. 1982 May 28;216(4549):1003-5. doi: 10.1126/science.7079745.
2
Seasonality in the occurrence of breast cancer.乳腺癌发病的季节性。
Cancer Res. 1983 Feb;43(2):892-6.
3
Melatonin increases oestrogen receptor binding activity of human breast cancer cells.褪黑素可增加人乳腺癌细胞的雌激素受体结合活性。
Nature. 1983;305(5932):323-5. doi: 10.1038/305323a0.
4
Variation in histology and oestrogen receptor content in breast carcinoma related to tumour size and time of presentation.
Clin Oncol. 1983 Sep;9(3):233-8.
5
Seasonal alterations and the natural history of malignant neoplasms.
Prog Clin Cancer. 1967;3:96-106.
6
Plasma melatonin and the hormone-dependency of human breast cancer.血浆褪黑素与人类乳腺癌的激素依赖性
J Clin Oncol. 1985 Jul;3(7):941-8. doi: 10.1200/JCO.1985.3.7.941.
7
Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status.乳腺癌检测中的季节性变化:与肿瘤孕激素受体状态的相关性。
Breast Cancer Res Treat. 1985;5(2):171-6. doi: 10.1007/BF01805991.
8
Seasonality and breast cancer.
Eur J Surg Oncol. 1985 Jun;11(2):143-6.
9
Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity.在一个光照具有强烈季节差异的地区,人体褪黑素与卵巢活动之间的反季节关系。
J Clin Endocrinol Metab. 1987 Nov;65(5):823-8. doi: 10.1210/jcem-65-5-823.
10
Association between season of first detection of breast cancer and disease progression.首次发现乳腺癌的季节与疾病进展之间的关联。
Breast Cancer Res Treat. 1987;9(3):227-32. doi: 10.1007/BF01806384.